Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Clinical trial NCT00515099 · TERMINATED
Trial details
- NCT number
- NCT00515099
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2012-06-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.